Roche holding aktiengesellschaft

美股醫療保健

RHHBY 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

公司發布財報數據季度不足,尚無法提供評分

RHHBY 近期報酬表現

1.45%

Roche holding aktiengesellschaft

0.68%

同產業平均

0.03%

S&P500

與 RHHBY 同產業的標的表現

  • MRNA Moderna inc
    價值 3 分趨勢 3 分波段 3 分籌碼 3 分股利 1 分
    查看更多

RHHBY 公司資訊

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

RHHBY 股價